NFEC [NF Energy Saving] CORRESP: (Original Filing)

[NF Energy Savings Corporation of America 21 Jia Bei Si Dong Road Tie Xi Qu Shenyang, PRC 110021 Filed via EDGAR 100 F. Street, NE Attention: Mr. John Cash, Branch Chief NF Energy Savings Corporation of America Form 10-K for the year ended December 31, 2008 File No. 0-50155 Dear Sirs: Form 10-K for the year ended December 31, 2008]

By | 2016-03-04T18:46:10+00:00 November 18th, 2009|Categories: Chinese Stocks, NFEC, SEC Original|Tags: , , , , , |0 Comments

NFEC [NF Energy Saving] CORRESP: NF Energy Savings Corporation of America 21 Jia

[NF Energy Savings Corporation of America 21 Jia Bei Si Dong Road Tie Xi Qu Shenyang, PRC 110021 Filed via EDGAR 100 F. Street, NE Attention: Mr. John Cash, Branch Chief NF Energy Savings Corporation of America Form 10-K for the year ended December 31, 2008 File No. 0-50155 Dear Sirs: Form 10-K for the year ended December 31, 2008]

By | 2016-03-04T18:47:31+00:00 November 18th, 2009|Categories: Chinese Stocks, NFEC, Webplus ver|Tags: , , , , , |0 Comments

CSIQ [Canadian Solar] 6-K: (Original Filing)

[Canadian Solar Reports Third Quarter 2009 Results Q309 Highlights • 87% increase in net revenues to $213.1 million, compared to Q209 net revenues of $114.2 million. • 113% increase in shipments of 102.6 MW, compared to Q209 shipments of 48.2 MW, setting a new quarterly shipping record. • Gross margin of 16.3%, compared to Q209 gross margin of 20.2% and] [CANADIAN SOLAR INC. Form 6-K TABLE OF CONTENTS EX-99.1 - Press Release CANADIAN SOLAR INC. Shawn (Xiaohua) Qu Chairman, President and]

By | 2016-03-16T15:32:32+00:00 November 18th, 2009|Categories: Chinese Stocks, CSIQ, SEC Original|Tags: , , , , , |0 Comments

CSIQ [Canadian Solar] 6-K: Canadian Solar Reports Third Quarter 2009 Results Q309

[Canadian Solar Reports Third Quarter 2009 Results Q309 Highlights • 87% increase in net revenues to $213.1 million, compared to Q209 net revenues of $114.2 million. • 113% increase in shipments of 102.6 MW, compared to Q209 shipments of 48.2 MW, setting a new quarterly shipping record. • Gross margin of 16.3%, compared to Q209 gross margin of 20.2% and] [CANADIAN SOLAR INC. Form 6-K TABLE OF CONTENTS EX-99.1 - Press Release CANADIAN SOLAR INC. Shawn (Xiaohua) Qu Chairman, President and]

By | 2016-03-16T15:34:07+00:00 November 18th, 2009|Categories: Chinese Stocks, CSIQ, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Third Quarter 2009 Financial Results - Conference call scheduled Monday, November 16, 2009 at 9:00 a.m. ET - BEIJING, Nov. 15 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009. Financial Highlights · Sales for the] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T03:59:18+00:00 November 18th, 2009|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Third Quarter 2009 Financial Results

[Sinovac Reports Unaudited Third Quarter 2009 Financial Results - Conference call scheduled Monday, November 16, 2009 at 9:00 a.m. ET - BEIJING, Nov. 15 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009. Financial Highlights · Sales for the] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T04:00:34+00:00 November 18th, 2009|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] F-3: (Original Filing)

[Law Debenture Corporate Services Inc. Copies to: st David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. o ý o o o o CALCULATION OF REGISTRATION FEE] [[Letterhead of Rhudd & Associates] November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Sirs, Sinovac Biotech Ltd. (the “Company”) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the “Prospectus”) contained] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road Haidian District, Beijing 100085 People’s Republic of China Ladies and Gentlemen: Company Securities Registration Statement We have acted as special U.S. counsel to Sinovac Biotech Ltd., a limited liability corporation incorporated in Antigua, West Indies (the “ The facts, as we understand them, and upon which with your permission we] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Sirs, Sinovac Biotech Ltd. (the “Company”) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the “Prospectus”) contained in the Registration Statement. We] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, November 18, 2009 Chartered Accountants]

By | 2016-03-24T04:02:09+00:00 November 18th, 2009|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] F-3: Law Debenture Corporate Services Inc. Copies to: st

[Law Debenture Corporate Services Inc. Copies to: st David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. o ý o o o o CALCULATION OF REGISTRATION FEE] [[Letterhead of Rhudd & Associates] November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Sirs, Sinovac Biotech Ltd. (the “Company”) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the “Prospectus”) contained] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road Haidian District, Beijing 100085 People’s Republic of China Ladies and Gentlemen: Company Securities Registration Statement We have acted as special U.S. counsel to Sinovac Biotech Ltd., a limited liability corporation incorporated in Antigua, West Indies (the “ The facts, as we understand them, and upon which with your permission we] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Sirs, Sinovac Biotech Ltd. (the “Company”) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the “Prospectus”) contained in the Registration Statement. We] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, November 18, 2009 Chartered Accountants]

By | 2016-03-24T04:03:30+00:00 November 18th, 2009|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar